These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 1835294)

  • 21. Therapeutic goals and treatment options for prevention of stress ulcer syndrome.
    Zuckerman GR; Shuman R
    Am J Med; 1987 Dec; 83(6A):29-35. PubMed ID: 3321975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stress ulcer prophylaxis in intensive care unit patients receiving enteral nutrition: a systematic review and meta-analysis.
    Huang HB; Jiang W; Wang CY; Qin HY; Du B
    Crit Care; 2018 Jan; 22(1):20. PubMed ID: 29374489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: an updated systematic review and network meta-analysis of randomized trials.
    Wang Y; Ge L; Ye Z; Siemieniuk RA; Reintam Blaser A; Wang X; Perner A; Møller MH; Alhazzani W; Cook D; Guyatt GH
    Intensive Care Med; 2020 Nov; 46(11):1987-2000. PubMed ID: 32833040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials.
    Alshamsi F; Belley-Cote E; Cook D; Almenawer SA; Alqahtani Z; Perri D; Thabane L; Al-Omari A; Lewis K; Guyatt G; Alhazzani W
    Crit Care; 2016 May; 20(1):120. PubMed ID: 27142116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis.
    Wang Y; Ye Z; Ge L; Siemieniuk RAC; Wang X; Wang Y; Hou L; Ma Z; Agoritsas T; Vandvik PO; Perner A; Møller MH; Guyatt GH; Liu L
    BMJ; 2020 Jan; 368():l6744. PubMed ID: 31907166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients.
    Jung R; MacLaren R
    Ann Pharmacother; 2002 Dec; 36(12):1929-37. PubMed ID: 12452757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress-ulcer prophylaxis for general medical patients: a review of the evidence.
    Janicki T; Stewart S
    J Hosp Med; 2007 Mar; 2(2):86-92. PubMed ID: 17427249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.
    Krag M; Perner A; Wetterslev J; Wise MP; Hylander Møller M
    Intensive Care Med; 2014 Jan; 40(1):11-22. PubMed ID: 24141808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group.
    Cook DJ; Fuller HD; Guyatt GH; Marshall JC; Leasa D; Hall R; Winton TL; Rutledge F; Todd TJ; Roy P
    N Engl J Med; 1994 Feb; 330(6):377-81. PubMed ID: 8284001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal therapy for stress gastritis.
    Maier RV; Mitchell D; Gentilello L
    Ann Surg; 1994 Sep; 220(3):353-60; discussion 360-3. PubMed ID: 8092901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current guidelines on stress ulcer prophylaxis.
    Tryba M; Cook D
    Drugs; 1997 Oct; 54(4):581-96. PubMed ID: 9339962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group.
    Cook D; Heyland D; Griffith L; Cook R; Marshall J; Pagliarello J
    Crit Care Med; 1999 Dec; 27(12):2812-7. PubMed ID: 10628631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Considerations for selection of parenteral histamine (H2)-receptor antagonists.
    Wolfe MM
    Am J Med; 1987 Dec; 83(6A):82-8. PubMed ID: 2892411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stress ulcer disease and its prevention].
    Gyr K; Meier R
    Schweiz Med Wochenschr; 1989 Apr; 119(13-14):423-9. PubMed ID: 2566200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients-protocol for a systematic review with meta-analysis and trial sequential analysis.
    Marker S; Perner A; Wetterslev J; Barbateskovic M; Jakobsen JC; Krag M; Granholm A; Anthon CT; Møller MH
    Syst Rev; 2017 Jun; 6(1):118. PubMed ID: 28646925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients.
    Stollman N; Metz DC
    J Crit Care; 2005 Mar; 20(1):35-45. PubMed ID: 16015515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reassessing the Use of Proton Pump Inhibitors and Histamine-2 Antagonists in Critically Ill Children: A Systematic Review and Meta-Analysis.
    Yao DWJ; Ong C; Eales NM; Sultana R; Wong JJ; Lee JH
    J Pediatr; 2021 Jan; 228():164-176.e7. PubMed ID: 32916144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prophylaxis for stress ulcer bleeding in the intensive care unit].
    Avendaño-Reyes JM; Jaramillo-Ramírez H
    Rev Gastroenterol Mex; 2014; 79(1):50-5. PubMed ID: 24629722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and treatment of stress ulcers in critically ill patients.
    Yang YX; Lewis JD
    Semin Gastrointest Dis; 2003 Jan; 14(1):11-9. PubMed ID: 12610850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.